Prolonged High-Level Detection of Retrovirally Marked Hematopoietic Cells in Nonhuman Primates after Transduction of CD34+ Progenitors Using Clinically Feasible Methods

This publication has 42 references indexed in Scilit:

• Retroviral Marking and Transplantation of Rhesus Hematopoietic Cells by Nonmyeloablative Conditioning
  Human Gene Therapy, 1999
• The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction.
  Proceedings of the National Academy of Sciences, 1996
• Gene Transfer into Hematopoietic Stem Cells of Nonhuman Primates
  Human Gene Therapy, 1996
• Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
  Nature Medicine, 1996
• Consistent and High Rates of Gene Transfer Can Be Obtained Using Flow-Through Transduction over a Wide Range of Retroviral Titers
  Human Gene Therapy, 1996
• Gene marking and gene therapy directed at primary hematopoietic cells
  Current Opinion in Hematology, 1996
• Retroviral Mediated Transfer of the Human Multidrug Resistance Gene (MDR-1) into Hematopoietic Stem Cells During Autologous Transplantation after Intensive Chemotherapy for Metastatic Breast Cancer. National Institutes of Health, Bethesda, Maryland
  Human Gene Therapy, 1994
• Comparison of the Effects of Growth Factors on Retroviral Vector-Mediated Gene Transfer and the Proliferative Status of Human Hematopoietic Progenitor Cells
  Human Gene Therapy, 1990
• Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells.
  Proceedings of the National Academy of Sciences, 1989
• Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.
  Journal of Clinical Investigation, 1987